Thermo Fisher Scientific (TMO) Total Debt (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported Total Debt for 18 consecutive years, with $43.2 billion the latest figure, recorded in Q1 2026.

• Total Debt for Q1 2026 came in at $43.2 billion, up 26.24% year-over-year; the trailing twelve-month figure through Mar 2026 was $43.2 billion (up 26.24% YoY), and the FY2025 annual result was $39.4 billion, up 25.93% from the prior year.
• Total Debt was $43.2 billion for Q1 2026 at Thermo Fisher Scientific, up from $39.4 billion in the prior quarter.
• Over five years, Total Debt peaked at $43.2 billion in Q1 2026 and troughed at $29.2 billion in Q4 2022.
• Average Total Debt over 5 years is $34.8 billion, with a median of $35.2 billion recorded in 2025.
• Year-over-year, Total Debt surged 78.36% in 2022 and decreased 10.43% in 2024.
• Over 5 years, Total Debt stood at $34.5 billion in 2022, then grew by 1.24% to $34.9 billion in 2023, then fell by 10.43% to $31.3 billion in 2024, then climbed by 25.93% to $39.4 billion in 2025, then gained by 9.59% to $43.2 billion in 2026.
• Per Business Quant data, the three most recent Total Debt figures were $43.2 billion in Q1 2026, $39.4 billion in Q4 2025, and $35.7 billion in Q3 2025.